Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladislav Pecen

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 15, 2023
Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registryRenate B Schnabel, Pietro Ameri, Jolanta M Siller-Matula, et al.
Journal of the American College of Cardiology|January 28, 2017
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AFGiuseppe Patti, Markus Lucerna, Ilaria Cavallari, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization TestVáclav Šimánek, Ladislav Pecen, Zuzana Krátká, et al.
Anticancer Research|December 27, 2011
Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markersRadek Kucera, Monika Cerna, Andrea Narsanska, et al.
Scientific Reports|January 29, 2025
Risk factors associated with higher WHO grade in meningiomas: a multicentric study of 552 skull base meningiomasMichaela May, Vojtech Sedlak, Ladislav Pecen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 5, 2022
Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysisIgor Diemberger, Stefano Fumagalli, Anna Maria Mazzone, et al.
European Heart Journal Open|March 31, 2025
Edoxaban treatment in routine clinical practice is highly concordant with the 2020 European Society of Cardiology atrial fibrillation guidelines: results from the noninterventional Global ETNA-AF programmeDoralisa Morrone, Leon Dinshaw, José Antonio Gordillo de Souza, et al.
Anticancer Research|April 22, 2011
Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancerVaclav Liska, Lubos Holubec, Vladislav Treska, et al.
Anticancer Research|July 2, 2014
Prevalence of perfusion defects detected by stress 99mtechnetium sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with breast cancerBohuslav Melichar, Jiří Doležal, Vlastislav Srámek, et al.
Anticancer Research|November 24, 2011
Prognostic significance of TIMP-1 in non-small cell lung cancerMartin Pesta, Vlastimil Kulda, Radek Kucera, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 15, 2023
Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registryRenate B Schnabel, Pietro Ameri, Jolanta M Siller-Matula, et al.
Journal of the American College of Cardiology|January 28, 2017
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AFGiuseppe Patti, Markus Lucerna, Ilaria Cavallari, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization TestVáclav Šimánek, Ladislav Pecen, Zuzana Krátká, et al.
Anticancer Research|December 27, 2011
Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markersRadek Kucera, Monika Cerna, Andrea Narsanska, et al.
Scientific Reports|January 29, 2025
Risk factors associated with higher WHO grade in meningiomas: a multicentric study of 552 skull base meningiomasMichaela May, Vojtech Sedlak, Ladislav Pecen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 5, 2022
Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysisIgor Diemberger, Stefano Fumagalli, Anna Maria Mazzone, et al.
European Heart Journal Open|March 31, 2025
Edoxaban treatment in routine clinical practice is highly concordant with the 2020 European Society of Cardiology atrial fibrillation guidelines: results from the noninterventional Global ETNA-AF programmeDoralisa Morrone, Leon Dinshaw, José Antonio Gordillo de Souza, et al.
Anticancer Research|April 22, 2011
Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancerVaclav Liska, Lubos Holubec, Vladislav Treska, et al.
Anticancer Research|July 2, 2014
Prevalence of perfusion defects detected by stress 99mtechnetium sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with breast cancerBohuslav Melichar, Jiří Doležal, Vlastislav Srámek, et al.
Anticancer Research|November 24, 2011
Prognostic significance of TIMP-1 in non-small cell lung cancerMartin Pesta, Vlastimil Kulda, Radek Kucera, et al.
Pageof 9